NURO

NeuroMetrix (NURO)

NeuroMetrix Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NURO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/01	02 : 15	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NASDAQ:NURO	NeuroMetrix Inc
2024/05/25	06 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/05/25	06 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/05/25	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/05/16	05 : 00	GlobeNewswire Inc.	NeuroMetrix Reports Q1 2024 Business Highlights	NASDAQ:NURO	NeuroMetrix Inc
2024/05/16	01 : 33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NURO	NeuroMetrix Inc
2024/05/16	00 : 19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NURO	NeuroMetrix Inc
2024/05/08	05 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/04/19	21 : 00	GlobeNewswire Inc.	NeuroMetrix Announces Steps Taken to Enhance Shareholder Value	NASDAQ:NURO	NeuroMetrix Inc
2024/03/14	22 : 00	GlobeNewswire Inc.	NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	NASDAQ:NURO	NeuroMetrix Inc
2024/03/13	22 : 00	GlobeNewswire Inc.	NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia	NASDAQ:NURO	NeuroMetrix Inc
2024/03/07	07 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/03/07	07 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/03/07	07 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/03/07	07 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NURO	NeuroMetrix Inc
2024/03/05	06 : 12	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NURO	NeuroMetrix Inc
2024/03/02	07 : 07	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:NURO	NeuroMetrix Inc
2024/02/28	06 : 45	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:NURO	NeuroMetrix Inc
2024/02/28	06 : 00	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:NURO	NeuroMetrix Inc
2024/02/27	07 : 41	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:NURO	NeuroMetrix Inc
2024/02/22	21 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NURO	NeuroMetrix Inc
2024/02/22	21 : 00	GlobeNewswire Inc.	NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights	NASDAQ:NURO	NeuroMetrix Inc
2024/02/21	04 : 49	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NURO	NeuroMetrix Inc
2024/02/15	23 : 00	GlobeNewswire Inc.	NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call	NASDAQ:NURO	NeuroMetrix Inc
2024/02/13	23 : 00	GlobeNewswire Inc.	NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value	NASDAQ:NURO	NeuroMetrix Inc
2023/12/12	23 : 00	GlobeNewswire Inc.	NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)	NASDAQ:NURO	NeuroMetrix Inc
2023/12/05	23 : 00	GlobeNewswire Inc.	NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)	NASDAQ:NURO	NeuroMetrix Inc
2023/11/20	23 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NURO	NeuroMetrix Inc
2023/11/20	23 : 00	GlobeNewswire Inc.	NeuroMetrix Announces One-for-Eight Reverse Stock Split	NASDAQ:NURO	NeuroMetrix Inc
2023/10/27	05 : 20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NURO	NeuroMetrix Inc